ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Considerations For Packaging Solutions For Cell And Gene Therapies

  Thinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.

• Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling

  See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.

• A Supply Chain Management Solution Designed for Clinical Research

  In this use case, follow along the clinical supplies management journey to learn how GxP Inventory replaces fragmented, spreadsheet-based processes to optimize visibility, traceability, and compliance.

• Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes

  Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.

• How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain

  In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.

• The Critical Role Of Clinical Trial Packaging Services In Trial Success

  Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.

• Clinical Manufacturing: What It Is And How It Works

  Clinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?

• Distributing Clinical Supply In The EU For Compassionate Use Programs

  Explore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.

• Advancing Your API To First Human Dose Trials More Efficiently

  Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.

• Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials

  Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.